Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2023-04-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의청약결과(자율공시)(실권주 일반공모분)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a capital increase (paid-in capital increase) through a public offering of unsubscribed shares. It details the subscription results, including the number of shares subscribed and the subscription rate. This falls under the category of share issuance and capital changes, specifically related to the outcome of a capital raising event.
2023-04-19 Korean
유상증자또는주식관련사채등의청약결과(자율공시)(구주주배정분)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Gencurix regarding the results of a rights offering (paid-in capital increase). It details the subscription results, including the number of shares subscribed, the subscription rate, and the handling of unsubscribed shares. This falls under the category of capital and financing updates, specifically related to share issuance and capital changes.
2023-04-14 Korean
유상증자최종발행가액확정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Gencurix regarding the finalization of the issue price for a capital increase (paid-in capital increase/rights offering). It details the number of shares, the final price per share, the calculation methodology, and references previous related filings. This falls under the category of share issuance and capital changes.
2023-04-10 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Gencurix, specifically detailing a 'Capital Increase' (유상증자결정). It outlines the purpose of the funds, the issuance price, the subscription method, and the timeline for the capital raise. This falls under the category of announcements regarding new share issues and capital changes.
2023-04-10 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the issuance price for a capital increase (유상증자) by Gencurix (젠큐릭스). This document is a formal regulatory filing required for capital raising activities, specifically detailing the pricing, dilution effects, and procedural updates for a share issuance. It fits the 'Capital/Financing Update' category as it pertains to the company's capital structure changes and financing activities.
2023-04-10 Korean
[기재정정]투자설명서
Investor Presentation Classification · 95% confidence The document is a 'Securities Registration Statement' (투자설명서) amendment (정정신고) filed by Gencurix. It details the final issuance price, capital structure changes, and dilution risks associated with a rights offering (유상증자). In the context of financial filings, a 'Securities Registration Statement' (투자설명서) is a primary regulatory document for capital raising. Since it is a formal regulatory filing detailing the terms of a capital increase, it falls under the 'Capital/Financing Update' category.
2023-04-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.